[Chemotherapy of reactive exudative pleurisy in breast carcinoma].
An analysis is carried out and the results from the treatment of 84 patients with metastasized mammary gland carcinoma and reactive exudative pleurisy are reported. Monochemiotherapy is applied in 61 patients (73%), mainly with cyclphosphamide and combined (poly) chemiotherapy in 23 patients (27%). A favourable effect on the exudative pluerisy is established in 75 per cent of all the patients treated: in 77 per cent of the treated with monochemiotherapy and 70 per cent of the treated with combined (poly) chemiotherapy. Favourable effect on exudative pleurisy was observed in 80 per cent of the patients treated with cyclophosphamide and complete exudation resorption was achieved in 2/3 of them.
D000328:Adult; D001943:Breast Neoplasms / Q000150:complications*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010998:Pleurisy / Q000188:drug therapy* / Q000209:etiology; D013852:Thiotepa / Q000627:therapeutic use; D014228:Triaziquone / Q000627:therapeutic use
D003520:Cyclophosphamide; D013852:Thiotepa; D014228:Triaziquone
Khimioterapiia na reaktivniia eksudativen plevrit pri kartsinoma na mlechnata zhleza